Omnicell (OMCL) Capital Expenditures Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Teladoc Health | 1.42 Bn | 672.39 Mn | 562.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.56% |
| Dec 31, 2025 | -223.79% |
| Sep 30, 2025 | 35.00% |
| Jun 30, 2025 | -15.19% |
| Mar 31, 2025 | -21.01% |
| Dec 31, 2024 | -28.75% |
| Sep 30, 2024 | -28.59% |
| Jun 30, 2024 | 71.54% |
| Mar 31, 2024 | 43.85% |
| Dec 31, 2023 | 33.57% |
| Sep 30, 2023 | -47.34% |
| Jun 30, 2023 | 7.40% |
| Mar 31, 2023 | 14.34% |
| Dec 31, 2022 | -15.97% |
| Sep 30, 2022 | -54.53% |
| Jun 30, 2022 | 18.92% |
| Mar 31, 2022 | 36.19% |
| Dec 31, 2021 | -2.39% |
| Sep 30, 2021 | 117.51% |
| Jun 30, 2021 | -106.84% |
| Mar 31, 2021 | 61.17% |
| Dec 31, 2020 | -43.25% |
| Sep 30, 2020 | -49.88% |
| Jun 30, 2020 | 29.88% |
| Mar 31, 2020 | 24.80% |
| Dec 31, 2019 | 83.97% |
| Sep 30, 2019 | 30.12% |
| Jun 30, 2019 | -16.60% |
| Mar 31, 2019 | -10.63% |
| Dec 31, 2018 | -43.16% |
| Sep 30, 2018 | 15.21% |
| Jun 30, 2018 | 42.78% |
| Mar 31, 2018 | -27.17% |
| Dec 31, 2017 | 1.42% |
| Sep 30, 2017 | -12.04% |
| Jun 30, 2017 | 8.81% |
| Mar 31, 2017 | 11.26% |
| Dec 31, 2016 | 46.11% |
| Sep 30, 2016 | -29.54% |
| Jun 30, 2016 | -44.34% |
| Mar 31, 2016 | -28.03% |
| Dec 31, 2015 | -7.31% |
| Sep 30, 2015 | 11.00% |